Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 237

1.

Prenatal antidepressant exposure is associated with risk for attention-deficit hyperactivity disorder but not autism spectrum disorder in a large health system.

Clements CC, Castro VM, Blumenthal SR, Rosenfield HR, Murphy SN, Fava M, Erb JL, Churchill SE, Kaimal AJ, Doyle AE, Robinson EB, Smoller JW, Kohane IS, Perlis RH.

Mol Psychiatry. 2015 Jun;20(6):727-34. doi: 10.1038/mp.2014.90. Epub 2014 Aug 26.

2.

Absence of evidence for increase in risk for autism or attention-deficit hyperactivity disorder following antidepressant exposure during pregnancy: a replication study.

Castro VM, Kong SW, Clements CC, Brady R, Kaimal AJ, Doyle AE, Robinson EB, Churchill SE, Kohane IS, Perlis RH.

Transl Psychiatry. 2016 Jan 5;6:e708. doi: 10.1038/tp.2015.190.

4.

Associations of Maternal Antidepressant Use During the First Trimester of Pregnancy With Preterm Birth, Small for Gestational Age, Autism Spectrum Disorder, and Attention-Deficit/Hyperactivity Disorder in Offspring.

Sujan AC, Rickert ME, Öberg AS, Quinn PD, Hernández-Díaz S, Almqvist C, Lichtenstein P, Larsson H, D'Onofrio BM.

JAMA. 2017 Apr 18;317(15):1553-1562. doi: 10.1001/jama.2017.3413.

5.

Antidepressant Use During Pregnancy and the Risk of Autism Spectrum Disorder in Children.

Boukhris T, Sheehy O, Mottron L, Bérard A.

JAMA Pediatr. 2016 Feb;170(2):117-24. doi: 10.1001/jamapediatrics.2015.3356.

PMID:
26660917
6.

Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study.

Man KKC, Chan EW, Ip P, Coghill D, Simonoff E, Chan PKL, Lau WCY, Schuemie MJ, Sturkenboom MCJM, Wong ICK.

BMJ. 2017 May 31;357:j2350. doi: 10.1136/bmj.j2350.

7.

Antidepressant Use in Pregnancy and the Risk of Attention Deficit with or without Hyperactivity Disorder in Children.

Boukhris T, Sheehy O, Bérard A.

Paediatr Perinat Epidemiol. 2017 Jul;31(4):363-373. doi: 10.1111/ppe.12378. Epub 2017 Jun 22.

PMID:
28640459
8.

Maternal Polycystic Ovary Syndrome and Risk for Attention-Deficit/Hyperactivity Disorder in the Offspring.

Kosidou K, Dalman C, Widman L, Arver S, Lee BK, Magnusson C, Gardner RM.

Biol Psychiatry. 2017 Nov 1;82(9):651-659. doi: 10.1016/j.biopsych.2016.09.022. Epub 2016 Oct 6.

9.

Attention deficit hyperactivity disorder and autism spectrum disorder in children born to mothers with thyroid dysfunction: a Danish nationwide cohort study.

Andersen SL, Laurberg P, Wu CS, Olsen J.

BJOG. 2014 Oct;121(11):1365-74. doi: 10.1111/1471-0528.12681. Epub 2014 Mar 10.

10.

[Pre- and perinatal risk factors in autism spectrum disorder and attention deficit/hyperactivity disorder].

Schmitz JC, Cholemkery H, Medda J, Freitag CM.

Z Kinder Jugendpsychiatr Psychother. 2017;45(3):209-217. doi: 10.1024/1422-4917/a000507. Epub 2017 Jan 27. German.

PMID:
28128013
11.

Association Between Serotonergic Antidepressant Use During Pregnancy and Autism Spectrum Disorder in Children.

Brown HK, Ray JG, Wilton AS, Lunsky Y, Gomes T, Vigod SN.

JAMA. 2017 Apr 18;317(15):1544-1552. doi: 10.1001/jama.2017.3415.

PMID:
28418480
12.

Prenatal exposure to fever is associated with autism spectrum disorder in the boston birth cohort.

Brucato M, Ladd-Acosta C, Li M, Caruso D, Hong X, Kaczaniuk J, Stuart EA, Fallin MD, Wang X.

Autism Res. 2017 Nov;10(11):1878-1890. doi: 10.1002/aur.1841. Epub 2017 Aug 11.

PMID:
28799289
13.

Prenatal maternal stress events and phenotypic outcomes in Autism Spectrum Disorder.

Varcin KJ, Alvares GA, Uljarević M, Whitehouse AJO.

Autism Res. 2017 Nov;10(11):1866-1877. doi: 10.1002/aur.1830. Epub 2017 Jul 6.

PMID:
28681538
14.

Interactive Effects of Prenatal Antidepressant Exposure and Likely Gene Disrupting Mutations on the Severity of Autism Spectrum Disorder.

Ackerman S, Schoenbrun S, Hudac C, Bernier R.

J Autism Dev Disord. 2017 Nov;47(11):3489-3496. doi: 10.1007/s10803-017-3246-6. Erratum in: J Autism Dev Disord. 2017 Sep 8;:.

PMID:
28770524
15.

Gestational Exposure to Selective Serotonin Reuptake Inhibitors and Offspring Psychiatric Disorders: A National Register-Based Study.

Malm H, Brown AS, Gissler M, Gyllenberg D, Hinkka-Yli-Salomäki S, McKeague IW, Weissman M, Wickramaratne P, Artama M, Gingrich JA, Sourander A.

J Am Acad Child Adolesc Psychiatry. 2016 May;55(5):359-66. doi: 10.1016/j.jaac.2016.02.013. Epub 2016 Mar 3.

16.

Attention deficit/hyperactivity disorder and childhood autism in association with prenatal exposure to perfluoroalkyl substances: a nested case-control study in the Danish National Birth Cohort.

Liew Z, Ritz B, von Ehrenstein OS, Bech BH, Nohr EA, Fei C, Bossi R, Henriksen TB, Bonefeld-Jørgensen EC, Olsen J.

Environ Health Perspect. 2015 Apr;123(4):367-73. doi: 10.1289/ehp.1408412. Epub 2014 Dec 19.

17.
18.

Maternal stress and perinatal features in autism and attention deficit/hyperactivity disorder.

Say GN, Karabekiroğlu K, Babadağı Z, Yüce M.

Pediatr Int. 2016 Apr;58(4):265-9. doi: 10.1111/ped.12822. Epub 2016 Feb 2.

PMID:
26338105
19.

Autism risk following antidepressant medication during pregnancy.

Viktorin A, Uher R, Reichenberg A, Levine SZ, Sandin S.

Psychol Med. 2017 Dec;47(16):2787-2796. doi: 10.1017/S0033291717001301. Epub 2017 May 22.

PMID:
28528584
20.

Identifying Unique Versus Shared Pre- and Perinatal Risk Factors for ASD and ADHD Using a Simplex-Multiplex Stratification.

Oerlemans AM, Burmanje MJ, Franke B, Buitelaar JK, Hartman CA, Rommelse NN.

J Abnorm Child Psychol. 2016 Jul;44(5):923-35. doi: 10.1007/s10802-015-0081-0.

Supplemental Content

Support Center